Acer Medical Inc.
Taipei Exchange 6857.TWO
Acer Medical Inc. Free Cash Flow Yield on January 14, 2025: -2.92%
Acer Medical Inc. Free Cash Flow Yield is -2.92% on January 14, 2025, a -55.57% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
-
Acer Medical Inc. 52-week high Free Cash Flow Yield is -1.73% on February 20, 2024, which is 40.66% above the current Free Cash Flow Yield.
-
Acer Medical Inc. 52-week low Free Cash Flow Yield is -2.92% on January 13, 2025, which is -0.14% below the current Free Cash Flow Yield.
-
Acer Medical Inc. average Free Cash Flow Yield for the last 52 weeks is -2.26%.
Key data
| Date | Free Cash Flow Yield | Market Value Added (MVA) | Price to Book Ratio (P/B) | Price to Earnings Ratio (P/E) |
|---|
Market news
Loading...
Taipei Exchange: 6857.TWO
| CEO | Mr. Yin Xiong Xu |
| IPO Date | March 4, 2022 |
| Location | |
| Headquarters | No. 88, Section 1, Xintai 5th Road |
| Employees | 22 |
| Sector | Technology |
| Industries | |
Description
Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. It offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email